Literature DB >> 6966050

Prolonged use of large intravenous steroid pulses in the rheumatic diseases of children.

J J Miller.   

Abstract

Nineteen children with rheumatic diseases refractory to standard treatment were given repeated large "pulses" of corticosteroid therapy. The pulses consisted of four repeated doses of 500 mg of hydrocortisone given intravenously over 20 to 30 minutes at six-hour intervals or of single intravenous injections of 30 mg/kg of methylprednisolone. All patients had temporary relief of signs or symptoms of inflammation. Complications were mild and only one child was removed from therapy because of a complication. Two children were judged to be treatment failures. Five patients have been weaned from all steroid treatment, and eight have required continued pulses at one- or two-week intervals as outpatients to maintain control. All of these have been able to reduce oral prednisone doses. Effects of the two forms of pulse appear similar. However, two children responded to the series of injections of hydrocortisone but not to single doses of methylprednisolone. Pulses have been given for periods up to three years without evident toxicity. Further work to define doses, schedules, and optimal drug is needed since this approach to steroid use appears effective and relatively nontoxic.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966050

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  Medical management of children with juvenile rheumatoid arthritis.

Authors:  J T Cassidy
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

2.  First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature.

Authors:  Rakesh Kumari; S S Uppal
Journal:  Rheumatol Int       Date:  2005-02-23       Impact factor: 2.631

Review 3.  Adrenal corticosteroids in the treatment of asthma.

Authors:  S C Siegel
Journal:  Clin Rev Allergy       Date:  1983-03

Review 4.  Juvenile rheumatoid arthritis: therapeutic perspectives.

Authors:  Ian C Chikanza
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  High dose methylprednisolone in severe acute transverse myelopathy.

Authors:  G Sébire; H Hollenberg; L Meyer; G Huault; P Landrieu; M Tardieu
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

6.  Effects of methylprednisolone infusions on vital signs in children with headaches.

Authors:  Elaine Heidrich; Gail Greene; Jessica Weberding; Li Lin; Susan McGee
Journal:  J Pediatr Pharmacol Ther       Date:  2013-01

7.  Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone.

Authors:  I A Williams; A D Mitchell; W Rothman; P Tallett; K Williams; P Pitt
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.